ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 5,950,000 shares, a decrease of 7.8% from the November 30th total of 6,450,000 shares. Based on an average daily volume of 4,970,000 shares, the days-to-cover ratio is currently 1.2 days. Currently, 12.8% of the shares of the company are short sold.
Analyst Ratings Changes
ASPI has been the topic of several research analyst reports. Canaccord Genuity Group reaffirmed a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 target price on the stock.
Check Out Our Latest Research Report on ASPI
ASP Isotopes Stock Performance
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in shares of ASP Isotopes during the third quarter worth approximately $6,249,000. Telemark Asset Management LLC acquired a new position in ASP Isotopes in the 3rd quarter valued at $4,726,000. Geode Capital Management LLC raised its position in ASP Isotopes by 42.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock worth $3,110,000 after buying an additional 334,836 shares during the last quarter. Philadelphia Financial Management of San Francisco LLC lifted its stake in shares of ASP Isotopes by 158.3% in the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after acquiring an additional 607,893 shares during the period. Finally, State Street Corp boosted its holdings in shares of ASP Isotopes by 12.8% in the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after acquiring an additional 96,604 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
- Five stocks we like better than ASP Isotopes
- How to Invest in Small Cap StocksĀ
- Work and Play: Investing in the Rise of Bleisure Travel
- Consumer Staples Stocks, Explained
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- What Does Downgrade Mean in Investing?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.